Lack of pharmacokinetic interaction between cholestyramine and acipimox, a new lipid lowering drug.
D000328:Adult; D002792:Cholestyramine Resin / Q000378:metabolism*; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D006801:Humans; D000960:Hypolipidemic Agents / Q000378:metabolism*; D007700:Kinetics; D011719:Pyrazines / Q000378:metabolism*; D011897:Random Allocation
D000960:Hypolipidemic Agents; D011719:Pyrazines; D002792:Cholestyramine Resin; C027696:acipimox